Zika virus (ZIKV) is an emerging arbovirus of the Flaviviridae family. Although ZIKV infection
is typically mild and self-limiting in healthy adults, infection has been associated with …

Zika virus (ZIKV) infection causees neurologic complications, including Guillain-Barré
syndrome in adults and central nervous system (CNS) abnormalities in fetuses. We …

CD8+ T cells may play a dual role in protection against and pathogenesis of flaviviruses,
including Zika virus (ZIKV). We evaluated the CD8+ T cell response in ZIKV-infected …

Animal models are critical to understand disease and to develop countermeasures for the
ongoing epidemics of Zika virus (ZIKV). Here we report a non-human primate model using a …

Zika virus (ZIKV) is an emerging mosquito-transmitted flavivirus that now causes epidemics
affecting millions of people on multiple continents. The virus has received global attention …

Zika virus (ZIKV) has gained worldwide attention since it emerged, and a global effort is
underway to understand the correlates of protection and develop diagnostics to identify rates …

Background Mosquito-borne Zika virus (ZIKV) typically causes a mild and self-limiting illness
known as Zika fever, which often is accompanied by maculopapular rash, headache, and …

Recent epidemics of Zika virus (ZIKV) have been associated with congenital malformation
during pregnancy and Guillain-Barré syndrome. There are two ZIKV lineages (African and …

Although Zika virus (ZIKV) was isolated approximately 70 years ago, few experimental
studies had been published prior to 2016. The recent spread of ZIKV to countries in the …

The emergence of Zika virus (ZIKV) in the Americas stimulated the development of multiple
ZIKV vaccine candidates. We previously developed two related DNA vaccine candidates …